Compare DAR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAR | CRL |
|---|---|---|
| Founded | 1882 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.6B |
| IPO Year | 2002 | 1999 |
| Metric | DAR | CRL |
|---|---|---|
| Price | $59.45 | $181.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $65.82 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 1.9M | 825.1K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $6,135,877,000.00 | $1,857,601,000.00 |
| Revenue This Year | $7.78 | N/A |
| Revenue Next Year | $3.37 | $3.04 |
| P/E Ratio | $73.21 | ★ N/A |
| Revenue Growth | 7.36 | ★ 10.48 |
| 52 Week Low | $29.15 | $143.06 |
| 52 Week High | $66.02 | $228.88 |
| Indicator | DAR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 58.25 |
| Support Level | $58.42 | $161.39 |
| Resistance Level | $65.46 | $184.75 |
| Average True Range (ATR) | 1.67 | 8.71 |
| MACD | -0.04 | 2.64 |
| Stochastic Oscillator | 31.50 | 85.03 |
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.